All Articles

Trace cord blood banking from 1980s discovery to modern regenerative therapies, covering key transplants, public/private banks, and current research.

Overview of how cord blood stem cells and exosomes aid heart repair—mechanisms, clinical evidence, delivery challenges, and future therapies.

Compare Americord’s upfront and 20-year cord blood costs, storage model, processing method, and $110,000 quality guarantee versus competitors.

Long-term studies show mesenchymal stem cell therapy is safe for Crohn's, sustaining remission for many patients with mainly localized side effects.

Cord blood stem cells reduce inflammation, promote neuron growth, and can improve recovery after traumatic brain injury — research, clinical trials, storage, and uses.

How umbilical cord mesenchymal stem cells repair tendons, ligaments, and cartilage, reduce inflammation, and improve recovery from sports injuries.

UCB-MSCs show higher tendon-specific markers, faster matrix formation and lower ectopic bone risk than BM-MSCs for tendon repair.

Precise temperature control—fresh cells at ~4°C, cryopreserved below −130°C—determines stem cell viability during transport.

Multi-center stem cell trials report regional heart repair and strong safety but mixed long-term efficacy, high costs, and data integrity concerns.